Navigation Links
New drug helps boost cancer treatment

Researchers at the Sloane Kettering Cancer Center, New York have achieved a breakthrough of sorts in cancer treatment, by designing a new drug, which attaches itself to a key position on cancer cells and gives new potency to failing chemotherapy drugs thereby extending survival of advanced colorectal cancer patients.

IMC-C225, the new drug which is actually a monoclonal antibody, is designed to interfere with the epidermal growth factor receptor, a molecular structure that, when blocked, makes it more difficult for tumor cells to reproduce.

To test the efficacy of the drug, the oncologists prescribed the new drug to a group of patients with cancer. All of the 120 patients given IMC-C225 were diagnosed with cancer that was progressing. When given the drug 22.5 percent of the patients achieved a partial response to therapy -- that is, their tumors were reduced by more than 50 percent. Another 7 percent of patients were able to have their disease stabilized.

Further studies of the drug are continuing in colorectal, head, neck, pancreatic and lung cancer. The monoclonal antibody was well tolerated by the patients. The most common side effect attributed to the drug was an acne-like skin rash that occurs because skin cells also contain large amounts of epidermal growth factor receptors.
'"/>




Page: 1

Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. Patient’s perception of health status helps in better recover
3. New vaccine helps allergy and asthma patients
4. New vaccine helps allergy and asthma patients
5. Now umbilical cord helps in stroke treatment.
6. Spirituality helps lessen arthritic pain
7. Supplement helps cardiac surgery
8. Antidepressant helps obesity
9. Dopamine helps stroke survivors
10. Radiotherapy helps in colon cancer
11. Genetics helps in attacking cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: